Submission of PSUR
“DCGI has made it mandatory for all manufacturers and importers who have obtain new drug permission to submit Periodic Safety Update Reports of new drug every six months for the first two year and for the subsequent two years it should be submitted annually”.
Recent Posts
Preparing for CDSCO Inspection: Documentation, Site Readiness, and Common Reasons for Delay
A CDSCO inspection is one of the most consequential events in a Medical Device company’s regulatory journey in India. Whether you are a manufacturer or Importer, demonstrating compliance with th..
Stem Cell Regulation in India: Separating Legitimate Therapy Development from Regulatory Risk
Introduction Stem cell therapy represents one of the most scientifically promising and regulatorily complex frontiers in modern medicine. India’s stem cell regulatory landscape presents both gen..
Cosmetic Labelling in India: CDSCO, , and Legal Metrology — Three Bodies, One Label
Three Regulatory Bodies, One Physical Label A Cosmetic label entering India is reviewed — directly or through market surveillance — against the requirements of three separate regulatory frameworks..
Need Help?
Submit your EnquiryOffice Locations
- Delhi
- Bangalore
- USA
- Singapore